Create Account Sign In
Morbidity of (adjuvant) CT/RT and impact on QoL
ESGO eAcademy. Nout R. 01/16/20; 293420 Topic: Complications
Prof. Dr. Remi Nout
Prof. Dr. Remi Nout
Contributions
DOCUMENT

Trending Content 

Molecular Integrated Risk Group Stratification & Testing for Molecular and Conventional Parameters: When, What,...
Concin N, Matías-Guiú X, Nout R, Bosse T. Mar 3, 2025
Flowchart Frenzy: Simplifying GTD Management
Joneborg U, Seckl M, Braicu E, Lok C. Jun 17, 2025
Surgical Cornerstones in the Management of EC Patients
Concin N, Nout R, Matías-Guiú X. Mar 18, 2025
Adjuvant Therapy: Whom and How to Treat?
Concin N, Nout R, Matías-Guiú X. May 22, 2025
Metastatic and Recurrent Endometrial Cancer
Concin N, Nout R, Matías-Guiú X, Marth C. Jun 24, 2025
Introduction to ESGO-ESTRO-ESP Updated Endometrial Cancer Guidelines (with ENGAGe)
Concin N. Feb 21, 2025
Molecular Integrated Risk Group Stratification
Nout R. Feb 21, 2025
Adjuvant Therapy: The Guide for Daily Clinical Decision-Making on Whom and How
Gonzalez Martin A. Feb 21, 2025
Surgical Cornerstones
Vergote I. Feb 21, 2025
Molecular and Conventional Parameters for Classification
Lax S. Feb 21, 2025

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies